Introduction: Interoceptive feedback to the brain regarding the body’s physiological state plays an important role in guiding motivated behaviors. For example, a state of negative energy balance tends to increase exploratory/food-seeking behaviors while reducing avoidance behaviors. We recently reported that overnight food deprivation reduces conditioned passive avoidance behavior in male (but not female) rats. Since fasting increases circulating levels of ghrelin, we hypothesized that ghrelin signaling contributes to the ability of fasting to reduce conditioned avoidance. Methods:Ad libitum-fed male rats were trained in a passive avoidance procedure using mild footshock. Later, following overnight food deprivation, the same rats were pretreated with ghrelin receptor antagonist (GRA) or saline vehicle 30 min before avoidance testing. Results: GRA restored passive avoidance in fasted rats as measured by both latency to enter and time spent in the shock-paired context. In addition, compared to vehicle-injected fasted rats, fasted rats that received GRA before reexposure to the shock-paired context displayed more cFos activation of prolactin-releasing peptide (PrRP)-positive noradrenergic (NA) neurons in the caudal nucleus of the solitary tract, accompanied by more cFos activation in downstream target sites of PrRP neurons (i.e., bed nucleus of the stria terminalis and paraventricular nucleus of the hypothalamus). Discussion: These results support the view that ghrelin signaling contributes to the inhibitory effect of fasting on learned passive avoidance behavior, perhaps by suppressing recruitment of PrRP-positive NA neurons and their downstream hypothalamic and limbic forebrain targets.

Avoiding danger is critical for survival, and animals are equipped with neural circuits that enable adaptive avoidance responses to stimuli previously associated with potentially dangerous, aversive experiences. However, excessive conditioned avoidance can be maladaptive, contributing to clinical anxiety and other stress-related disorders [1‒3]. Conditioned avoidance responses are based on learning and memory processes that include both conscious and subconscious components. Sensory feedback from body to brain during the learning and expression of emotional responses plays a major role in the subconscious modulation of motivated behavior [4]. For example, short-term negative energy balance generally biases animals toward approach behaviors and away from avoidance behaviors, thereby facilitating exploratory food-seeking [5, 6]. In recent work, we demonstrated a reduction in learned passive avoidance behavior in male rats that were tested following an overnight fast [7]. The present study was designed to investigate potential mechanisms and neural circuits through which interoceptive signals related to overnight food deprivation may act to suppress conditioned passive avoidance behavior.

Interoceptive feedback about the internal state of the body is continuously communicated to the brain through hormonal and neural pathways. The neural pathways feature vagal afferent inputs to the caudal nucleus of the solitary tract (cNTS) that can powerfully modulate motivated behavior [4, 8‒10]. Vagal afferents communicate a diverse array of cardiovascular, respiratory, gastrointestinal, and inflammatory signals to the cNTS in a manner that is further modulated by the hormonal and metabolic state [11‒15]. Within the cNTS, the A2 noradrenergic (NA) cell group receives direct synaptic input from vagal sensory afferents [16, 17], and A2 neurons are activated to express the immediate-early gene product, cFos, in response to vagal sensory stimulation [17‒20]. Central NA signaling pathways are highly implicated in interoceptive state-dependent modulation of feeding and other motivated behaviors, and genetically distinct subpopulations of brainstem NA neurons appear to play different behavioral roles [21]. For example, stimulation of catecholaminergic NTS neurons (likely including A2 neurons) projecting to the mediobasal hypothalamus is sufficient to increase food intake in mice [22], whereas food intake is suppressed after stimulation of A2 neuronal projections to the parabrachial nucleus [23]. Thus, separate populations of NA neurons may exert distinct effects on different types of motivated behavior.

A caudal subset of A2 neurons that coexpress prolactin-releasing peptide (PrRP) become activated to express cFos in rats exposed to a variety of innate and conditioned stressors that suppress food intake and promote avoidance behavior [6, 7, 24, 25]. Interestingly, overnight food deprivation markedly reduces the ability of these innate and conditioned stress stimuli to activate PrRP+ A2 neurons [6, 7], concurrent with reduced cFos activation in hypothalamic and limbic forebrain regions that are innervated by PrRP+ neurons, including the paraventricular nucleus of the hypothalamus (PVN) [19] and the anterior ventrolateral bed nucleus of the stria terminalis (vlBNST) [6, 7].

Food deprivation increases circulating levels of acyl-ghrelin [26‒28], and acyl-ghrelin reduces tonic firing and stimulus-induced responsiveness of vagal sensory neurons [29, 30] and postsynaptic A2 neurons in the cNTS [31]. We recently demonstrated that systemic administration of a ghrelin receptor antagonist in fasted rats partially restores the ability of vagal sensory stimulation to activate PrRP+ A2 neurons and suppress food intake [20]. Further, caloric restriction reduces innate avoidance behavior in wild-type mice but not in mice lacking ghrelin receptors [5], which display more innate anxiety-like behavior than wild-type mice [32]. Consistent with these anxiolytic effects of ghrelin signaling, baseline acyl-ghrelin levels prior to auditory fear conditioning negatively predict conditioned freezing behavior in rats [33]. However, the potential impact of ghrelin signaling on the expression of learned avoidance has not been examined. Based on our previous research demonstrating that rats fasted overnight display less passive avoidance behavior and less fear context-induced neural cFos activation [7], the present study was designed to test the hypothesis that increased ghrelin receptor signaling contributes to the ability of overnight food deprivation to suppress learned passive avoidance behavior, and to suppress conditioned context-induced activation of PrRP+ neurons in the cNTS and their downstream targets in the PVN and anterior vlBNST.

All experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were reviewed and approved by the Florida State University Animal Care and Use Committee (approval number 202000001).

Passive Avoidance Task

Adult male Sprague Dawley rats (Envigo; N = 32 [250–300 g body weight]) were pair-housed in standard tub cages in a temperature- and light-controlled housing environment (lights on from 04:00 h to 16:00 h). Only male rats were used in the current study based on evidence that food deprivation does not significantly reduce conditioned passive avoidance in female rats [7]. Rats were acclimated to handling for 3 days, with free access to water and rat chow (Purina 5001). Rats underwent passive avoidance training in a novel light/dark shuttle box (Coulbourn Instruments, Allentown, PA, USA), with training performed 4–6 h after lights on. The light/dark box comprised a light (illuminated) chamber with clear plastic walls and a smooth white plastic floor, and a dark (nonilluminated) chamber with black plastic walls and a metal grid floor. Each chamber measured 25 × 25 cm, with 28-cm-high walls and a ceiling. The two chambers were separated by a metal divider wall with a guillotine door that could be opened and closed remotely. For passive avoidance training, rats were initially placed individually into the light chamber of the box and the dividing guillotine door was lifted immediately to allow access to the dark chamber. As expected, due to their innate aversion to the light and preference for the dark, rats very quickly entered the dark chamber (average latency = 22.73 s). Upon entry into the dark chamber, the guillotine door was closed. After a 5-s delay, rats received a single mild electric footshock (0.6 mA; 1 s). Rats remained in the enclosed dark chamber for 30 s following footshock and then were returned to their home cage. Cagemates were similarly trained on the same day.

Two hours before dark onset on the day before testing (i.e., 2 days after training), all rats were transferred to clean cages with chow removed to initiate overnight food deprivation. On the next day, 4–6 h after lights on, rats received either an intraperitoneal (i.p.) injection of 0.15 M NaCl (saline) vehicle (∼0.3 mL) or the same volume of vehicle containing ghrelin receptor antagonist (GRA; [D-Lys3]-GHRP-6; 3.3 mg/kg BW; Sigma-Aldrich G4535). This GRA dose was based on our previous report demonstrating its ability to restore cholecystokinin-induced NTS neuronal cFos activation in food-deprived rats [20]. Thirty minutes later, rats were tested for passive avoidance retention. For this purpose, rats were placed individually into the light chamber of the light/dark box, the guillotine door was opened, and the latency of rats to fully enter the dark chamber was recorded, with a preset maximum latency of 900 s (15 min). During the retention test, the guillotine door remained open and no footshock was administered. Rats were allowed to freely explore both the light and dark chambers during the 900-s test, and total time spent within each chamber was recorded. After testing was complete, rats were returned to their home cages. Chow was not returned until 2 h prior to dark onset (i.e., approximately 6–8 h after testing).

To confirm that GRA treatment does not alter conditioned avoidance behavior in nonfasted rats, a separate cohort of adult male rats (n = 4) was trained in the passive avoidance task as described above. Two days later, rats were tested in an ad libitum-fed state, 30 min after receiving i.p. injection of GRA.

Novel Object Recognition Task

To examine the impact of GRA on general memory function, rats (N = 32) were tested for novel object recognition at least 5 days after completing passive avoidance testing. For this, rats underwent 3 days of acclimation (10 min/day) to a previously novel tub cage that had a thin layer of bedding on the floor, with the tub enclosed in an illuminated sound-attenuating chamber. On the 4th day, rats underwent object training 4–6 h after lights on, during which two similarly sized but geometrically distinct ceramic objects with rounded contours (i.e., a white pyramidal “Eiffel tower” and a blue spherical “rocket ship”) were placed at opposite ends of the tub cage. Rats were allowed to freely explore both objects for 15 min, while their behavior was recorded and later analyzed using behavior analysis software (ANY-maze, Stoelting Co.). During training, there was no significant difference between time spent with either object, defined as the rat being in contact with or actively examining the object.

Two hours before dark onset on the day before testing (i.e., 2 days after object training), all rats were transferred to clean cages with chow removed. On the subsequent day, fasted rats received either an i.p. injection of saline vehicle (∼0.3 mL) or the same volume of vehicle containing GRA (3.3 mg/kg BW). Thirty minutes later, rats were tested for novel object recognition. For this, the previously explored “Eiffel tower” object was replaced with a novel object (i.e., a gray cube-shaped “robot”). Rats were allowed to freely explore the novel and familiar objects for 15 min. The time each rat spent exploring each object was recorded, and the discrimination index was calculated as the difference between time spent with each object divided by the total time spent with either object:

graphic

In the discrimination index, a value of 0 indicates no discrimination between the novel and familiar objects. A positive value indicates more time spent with the novel object, whereas a negative value indicates more time spent with the familiar object. One rat from each injection group was excluded from analysis after one of the objects was knocked over during the novel object recognition test.

Open Field Test

To examine the impact of GRA on general locomotion and anxiety-like behavior, the same rats (N = 32) were tested in the open field after overnight food deprivation. On the testing day (4–6 h after lights on), fasted rats received either an i.p. injection of saline vehicle (∼0.3 mL) or the same volume of vehicle containing GRA (3.3 mg/kg BW). Thirty minutes later, rats were placed into the center of a novel 95 × 95 cm open arena and then left to freely explore for 10 min. Behavior in the open field was recorded using a Logitech webcam and was analyzed using automated behavior analysis software (ANY-maze, Stoelting Co.). Locomotion was defined as the total distance traveled during the test. Anxiety-like behaviors were interpreted based on time spent in the center zone of the field (∼30 × 30 cm) and latency to first enter the center zone. Data from one cohort of rats (n = 4/injection group) were excluded due to lighting issues in the testing room.

Context Reexposure and Perfusions

To examine neural cFos activation in response to the conditioned context associated with footshock, a subset of rats used in the behavioral studies described above (N = 24) were retrained in the passive avoidance task in which they were placed into the light side of the light/dark box. When rats entered the dark chamber (average latency = 133.93 s), the guillotine door closed behind them. Shock-retrained rats immediately received a mild electric footshock. Another cohort of rats (N = 12) were placed into the light side of the light/dark box but did not receive the footshock upon entry into the dark chamber. Rats in both the shock-retrained (i.e., shocked) and nonshocked groups were kept in the dark chamber for 30 s before being returned to their home cages. Two days later, 2 h before dark onset, all rats were transferred to clean cages with chow removed to initiate overnight food deprivation. On the next day, 4–6 h after lights on, fasted rats in both groups received either an i.p. injection of 0.15 M NaCl (saline) vehicle (∼0.3 mL) or the same volume of vehicle containing GRA (3.3 mg/kg BW). Thirty minutes later, rats were placed directly into the dark chamber (an aversively conditioned stimulus in the shock-retrained group but not in the nonshocked group) for 10 min with the guillotine door shut; rats were then returned to their homecage. Sixty minutes later, rats were deeply anesthetized with pentobarbital sodium (39 mg/mL i.p., Fatal Plus Solution; Butler Schein) and transcardially perfused with saline (100 mL) followed by 4% paraformaldehyde (500 mL).

Histology

Fixed brains were removed from the skull, postfixed overnight at 4˚C, and then cryoprotected in 20% sucrose. Brains were blocked and sectioned coronally (35 μm) using a Leica freezing-stage sliding microscope. Tissue sections were collected in six serial sets and stored at −20°C in cryopreservant solution [34] until immunohistochemical processing. Primary and secondary antisera were diluted in 0.1 M phosphate buffer containing 0.3% Triton X-100 and 1% normal donkey serum. One set of tissue sections from each rat (with each set containing a complete rostrocaudal series of sections spaced by 210 μm) was incubated in a rabbit polyclonal antiserum against cFos (1:10,000; Cell Signaling, 2250; AB_2247211), followed by biotinylated donkey anti-rabbit IgG (1:500; Jackson ImmunoResearch). Sections were then treated with Elite Vectastain ABC reagents (Vector) and reacted with diaminobenzidine intensified with nickel sulfate to produce a blue-black nuclear cFos reaction product. To visualize cFos within hindbrain PrRP neurons using dual immunoperoxidase, one set of cFos-labeled tissue sections from each rat was subsequently incubated in a rabbit polyclonal antiserum against PrRP (1:10,000; Phoenix Pharmaceuticals, H-008-52), followed by biotinylated donkey anti-rabbit IgG (1:500; Jackson ImmunoResearch) and Elite Vectastain ABC reagents (Vector), and finally reacted with plain diaminobenzidine to produce a brown cytoplasmic reaction product.

To visualize cFos within all NA neurons using dual immunofluorescence, a second set of tissue from each rat was incubated in a cocktail of rabbit anti-cFos (1:1,000) and a mouse monoclonal antiserum against dopamine beta-hydroxylase (DbH; 1:5,000; Millipore, MAB308; AB_2245740), followed by a cocktail of Cy3-conjugated donkey anti-rabbit IgG (red) and Alexa Fluor 488-conjugated donkey anti-mouse IgG (green).

Quantification of cFos Expression

Sections through the cNTS (∼15.46–13.15 mm caudal to bregma) were imaged at 20x using a Keyence microscope (BZ-X700). Using separate sets of dual-labeled tissue sections from each rat, the total numbers of DbH+ and PrRP+ cNTS neurons were counted, and the percentage of each chemically identified neural population coexpressing cFos was determined. Individual neurons were considered cFos positive if their nucleus contained cFos immunolabeling (regardless of intensity) surrounded by visible cytoplasmic DbH or PrRP immunolabeling within the same focal plane.

Sections through the anterior vlBNST (∼0.26–0.40 mm caudal to bregma) were imaged at 10x. Images from two rats were excluded from further analysis due to poor tissue quality. Using ImageJ, a circular region of interest (ROI) of 0.10 mm2 was centered on the area containing the highest density of DbH+ fibers and terminals corresponding to the fusiform subnucleus of the anterior vlBNST [6, 35, 36]. The number of cFos-positive nuclei within each 0.10 mm2 ROI was determined bilaterally in 2–3 sections per brain and averaged across assessed ROIs in each animal.

Three sections through the PVN (∼1.5–1.9 mm caudal to bregma) were imaged at 10x bilaterally per brain. An ROI encompassing the DbH+ fibers and terminals was drawn using ImageJ, and the number of cFos-positive nuclei within each ROI was determined, divided by the area of the ROI, and averaged across assessed ROIs in each animal to produce the number of cFos-positive neurons per mm2.

Ghrelin ELISA

After finding that GRA treatment significantly impacted conditioned avoidance behavior and cFos activation (see Results), we sought to confirm our assumption that plasma acyl-ghrelin levels increase in rats exposed to single and repeated sessions of overnight food deprivation. For this, terminal blood samples were collected from a separate cohort of adult male rats that were either ad libitum fed with no fasting experience (n = 3), fasted once overnight before morning blood collection (n = 3), or fasted overnight on 3 separate occasions (with at least 2 days between each episode) with the 3rd fast occurring before morning blood collection (n = 4). Prior to blood collection, rats were injected with pentobarbital sodium (39 mg/mL i.p., Fatal Plus Solution; Butler Schein), and blood samples were collected within 5 min from the right atrium of the heart using a 3-mL syringe prerinsed with 1% EDTA. Blood samples were transferred to a K2E EDTA vacuette tube (BD Ref 367841), and aprotinin (50 µL/mL) was added to each sample. Samples were centrifuged at 3,500 rpm for 10 min at 4°C to separate the plasma. Hydrochloride was added to the supernatant (10 µL/100 mL) centrifuging again at 3,500 rpm for 5 min at 4°C. Plasma samples were stored at −80°C. Acyl-ghrelin was measured using an ELISA kit (BioVendor, R&D; RA394062400R) according to the manufacturer's instructions.

Statistics

Data were analyzed using GraphPad Prism. Passive avoidance behaviors (latency to enter and total time spent in the dark chamber) during the retention test were analyzed using a Welch’s t test [37]. Time spent exploring novel versus familiar objects in the novel object recognition task was analyzed with a mixed 2 × 2 ANOVA with i.p. injection as a between-subjects independent variable and Object (novel, familiar) as a within-subjects independent variable. When ANOVA F values indicated significant main effects and/or interactions, post hoc comparisons were made using Šídák's multiple comparisons tests. Discrimination indices for novel object recognition by each i.p. injection group of rats were analyzed using Welch’s t test, and by individual one-subject t tests with a hypothetical value of 0 (i.e., no discrimination). Each open field behavioral measure (distance traveled, time in center, and latency to first enter the center) was analyzed separately with a Welch’s t test to compare i.p. injection groups. Cell count data (cFos activation of PrRP and DbH neurons, cFos activation within the anterior vlBNST and PVN) were analyzed using between-subjects 2 × 2 ANOVA with previous shock-pairing and i.p. treatment (i.e., GRA vs. vehicle) as independent variables. In addition, Pearson’s r correlations were run between the percentage of DbH+/PrRP+ cNTS neurons expressing cFos and cFos counts within vlBNST/PVN in the same rat. Plasma acyl-ghrelin data were analyzed using a one-way ANOVA with food deprivation history as the independent variable. An alpha level of 0.05 (p ≤ 0.05) was used as the criterion for considering group differences to be statistically significant. Estimation statistics were used to report effect sizes for both passive avoidance behavior and cell count data [38, 39].

Passive Avoidance Task

To expand upon previous findings demonstrating that male rats display less conditioned passive avoidance behavior when tested in a food-deprived state [7], the present study sought to examine whether blocking ghrelin signaling in fasted rats would restore passive avoidance behavior. Indeed, fasted rats injected with GRA demonstrated more passive avoidance behavior than fasted rats injected with saline. Compared to saline-treated fasted rats, GRA-treated fasted rats took longer to enter the shock-paired dark chamber (t(26.1) = 1.728; p = 0.0479) and spent less time in the dark chamber (t(18.67) = 2.162; p = 0.0219) during the testing period (Fig. 1). Specifically, fasted GRA-treated rats took an average of 195 s (3.25 min) longer to enter the shock-paired dark chamber compared to saline-injected controls (95% CI: −11.4 s, 419 s) and spent an average of 178 s (2.97 min) less time in the shock-paired dark chamber during the 900-s retention test (95% CI: 47.2 s, 369 s). Thus, pharmacological blockade of ghrelin signaling enhanced conditioned passive avoidance in fasted rats.

Fig. 1.

Systemic GRA administration prior to the retention test increased passive avoidance behavior in food-deprived male rats. a A schematic depicting the passive avoidance experimental timeline. b Rats pretreated with GRA took an average of 195 s longer to enter the shock-paired dark chamber compared to rats pretreated with saline. c Rats pretreated with GRA spent an average of 178 s less in the shock-paired dark chamber during the 900 s retention test compared to rats pretreated with saline. *p< 0.05. Graphs display group mean ± SEM, with individual data points plotted.

Fig. 1.

Systemic GRA administration prior to the retention test increased passive avoidance behavior in food-deprived male rats. a A schematic depicting the passive avoidance experimental timeline. b Rats pretreated with GRA took an average of 195 s longer to enter the shock-paired dark chamber compared to rats pretreated with saline. c Rats pretreated with GRA spent an average of 178 s less in the shock-paired dark chamber during the 900 s retention test compared to rats pretreated with saline. *p< 0.05. Graphs display group mean ± SEM, with individual data points plotted.

Close modal

To examine whether GRA treatment by itself might alter conditioned passive avoidance, a separate group of avoidance-trained, nonfasted rats (n = 4) were treated with GRA before the test. These rats displayed a long average latency to enter (895.75 s ± 4.25) and minimal time in the shock-paired dark chamber (1 s ± 1), quite similar to the behavior of fasted GRA-treated rats shown in Figure 1. The similarly robust conditioned avoidance behavior displayed by nonfasted and fasted GRA-treated rats also was similar to published data from our laboratory obtained from avoidance-trained, nonfasted male rats with no i.p. treatment prior to testing [7]. Thus, pharmacological blockade of ghrelin receptors by itself has no apparent effect on conditioned passive avoidance in nonfasted rats.

Novel Object Recognition Task

We considered the possibility that the GRA enhanced passive avoidance behavior in fasted rats due to pharmacological enhancement of memory-based performance. To test this possibility, we examined whether GRA improved performance in a novel object recognition task. Pretest treatment with GRA did not alter the behavior of fasted rats in this task (Fig. 2). Rats demonstrated that they successfully learned the task as indicated by a significant main effect of Object on exploration time (F(1, 28) = 15.59; p = 0.0005), but there was no main effect of i.p. treatment on exploration time and no interaction. Specifically, fasted rats spent significantly more time exploring the novel object compared to the familiar object in both the saline- (p = 0.0093) and GRA-injected (p = 0.0361) groups. The discrimination indices for both the saline- (t(14) = 3.575, p = 0.0030) and GRA-injected groups (t(14) = 2.294, p = 0.0378) were significantly higher than 0, evidence that both groups were similarly able to discriminate between the familiar and novel objects. Thus, pharmacological blockade of ghrelin receptors does not alter general memory in fasted rats as assessed by performance in the novel object recognition task.

Fig. 2.

Systemic GRA administration prior to the novel object test did not influence novel object recognition memory in food-deprived male rats. a A schematic depicting the novel object recognition training and test. b Both GRA- and saline-pretreated rats spent significantly more time with the novel object compared to the familiar object. c The discrimination index for both GRA- and saline-pretreated rats was similar and significantly greater than zero. Graphs display group mean ± SEM, with individual data points plotted. *p< 0.05 and **p< 0.01.

Fig. 2.

Systemic GRA administration prior to the novel object test did not influence novel object recognition memory in food-deprived male rats. a A schematic depicting the novel object recognition training and test. b Both GRA- and saline-pretreated rats spent significantly more time with the novel object compared to the familiar object. c The discrimination index for both GRA- and saline-pretreated rats was similar and significantly greater than zero. Graphs display group mean ± SEM, with individual data points plotted. *p< 0.05 and **p< 0.01.

Close modal

Open Field Test

We also considered the possibility that the effect of GRA to enhance passive avoidance behavior in fasted rats was due to a general effect on locomotor or anxiety-like behavior. To test this, we examined whether GRA treatment of fasted rats altered these behaviors during 10-min exposure to a novel open field. As shown in Figure 3a, fasted rats displayed similar locomotor behavior (i.e., total distance traveled) regardless of saline (mean = 17.9 m) or GRA treatment (mean = 17.3 m). There were also no significant effects of GRA on anxiety-like behaviors as measured by either time spent in the center of the open field (Fig. 3b) or latency to first enter the central zone (Fig. 3c). Thus, pharmacological blockade of ghrelin receptors does not alter general locomotor or anxiety-like behavior in fasted rats as assessed in a 10-min novel open field test.

Fig. 3.

Systemic GRA administration prior to the open field test did not influence locomotion or anxiety-like behavior in food-deprived male rats. a GRA- and saline-pretreated rats did not differ in the distance traveled during the open field test. b GRA- and saline-pretreated rats did not differ in the time spent in the center zone of the open field test. c GRA- and saline-pretreated rats did not differ in the latency to enter the center zone in the open field test. Graphs display group mean ± SEM, with individual data points plotted.

Fig. 3.

Systemic GRA administration prior to the open field test did not influence locomotion or anxiety-like behavior in food-deprived male rats. a GRA- and saline-pretreated rats did not differ in the distance traveled during the open field test. b GRA- and saline-pretreated rats did not differ in the time spent in the center zone of the open field test. c GRA- and saline-pretreated rats did not differ in the latency to enter the center zone in the open field test. Graphs display group mean ± SEM, with individual data points plotted.

Close modal

cFos Expression after Dark Chamber Reexposure

We previously reported that PrRP+ A2 neurons are activated to express cFos when ad libitum-fed rats are reexposed to the (previously footshock-paired) dark chamber, whereas these neurons do not express cFos in fasted rats undergoing the same reexposure condition [7]. The present study examined whether GRA restores A2 neural cFos activation in fasted rats after dark chamber reexposure. PrRP+ neurons in fasted rats were responsive to the shock-paired dark chamber as indicated by a significant main effect of shock training (F(1, 30 = 14.02; p < 0.001). We also observed a trending main effect of GRA treatment prior to dark chamber reexposure (F(1, 30) = 3.14; p = 0.087) and a trending interaction between shock training and GRA treatment (F(1, 30) = 3.33; p = 0.078; Fig. 4a). Specifically, cFos expression in PrRP+ neurons was elevated in shock-retrained fasted rats treated with GRA compared to rats treated with saline before dark chamber reexposure (p = 0.010). Approximately 12.1% more PrRP+ neurons were activated to express cFos in shock-retrained, fasted rats pretreated with GRA before dark chamber reexposure compared to cFos activation of PrRP+ neurons in similarly shock-retrained, fasted rats treated with saline before dark chamber reexposure (95% CI: 2.39%, 21.9%). Conversely, there was no GRA-related effect on PrRP+ neural cFos activation in fasted rats that were not shocked during training. A significant interaction between shock training and GRA treatment (F(1, 32) = 7.29; p = 0.011) on cFos activation of DbH+ neurons also was present (Fig. 4d), with no main effects of either condition. Specifically, GRA treatment increased DbH+ cFos expression in shock-retrained rats that were reexposed to the dark chamber (p = 0.024), which activated 11.9% more DbH+ neurons in GRA-treated versus saline-treated rats (95% CI: 1.59%, 20.4%). Conversely, GRA had no effect on DbH+ neuronal cFos activation in nonshocked rats.

Fig. 4.

In food-deprived male rats, systemic GRA administration prior to dark chamber reexposure increased cFos expression in cNTS neurons in rats that were retrained with footshock in the dark chamber (Shock +), but not in rats that were not shocked during training (Shock −). a GRA pretreatment increased shock-paired dark chamber-induced cFos activation of PrRP+ neurons. b, c Representative images taken at 40× magnification of nuclear cFos (dark blue) and cytoplasmic PrRP immunolabeling (brown) in saline vehicle- (b) and GRA-treated (c) rats that were shock retrained before being reexposed to the shock-paired dark chamber. Black arrows indicate double-labeled (cFos+) PrRP+ cells. d GRA pretreatment increased shock-paired dark chamber-induced cFos activation of the broader population of DbH+ A2 neurons. e, f Representative images taken at 40× magnification of nuclear cFos (red) and cytoplasmic DbH immunolabeling (green) in saline vehicle- (e) and GRA-pretreated (f) rats that were shock retrained before being reexposed to the shock-paired dark chamber. White arrows indicate double-labeled (cFos+) DbH+ cells. Graphs display group mean ± SEM, with individual data points plotted. *p< 0.05. Scale bar in b = 100 µm, applies also to c, e, and f.

Fig. 4.

In food-deprived male rats, systemic GRA administration prior to dark chamber reexposure increased cFos expression in cNTS neurons in rats that were retrained with footshock in the dark chamber (Shock +), but not in rats that were not shocked during training (Shock −). a GRA pretreatment increased shock-paired dark chamber-induced cFos activation of PrRP+ neurons. b, c Representative images taken at 40× magnification of nuclear cFos (dark blue) and cytoplasmic PrRP immunolabeling (brown) in saline vehicle- (b) and GRA-treated (c) rats that were shock retrained before being reexposed to the shock-paired dark chamber. Black arrows indicate double-labeled (cFos+) PrRP+ cells. d GRA pretreatment increased shock-paired dark chamber-induced cFos activation of the broader population of DbH+ A2 neurons. e, f Representative images taken at 40× magnification of nuclear cFos (red) and cytoplasmic DbH immunolabeling (green) in saline vehicle- (e) and GRA-pretreated (f) rats that were shock retrained before being reexposed to the shock-paired dark chamber. White arrows indicate double-labeled (cFos+) DbH+ cells. Graphs display group mean ± SEM, with individual data points plotted. *p< 0.05. Scale bar in b = 100 µm, applies also to c, e, and f.

Close modal

Having established that GRA treatment increased the ability of the footshock-conditioned context to activate cFos in DbH+/PrRP+ A2 neurons in fasted rats, we next examined cFos activation within two specific forebrain regions that receive dense input from hindbrain A2 neurons, the vlBNST and the PVN. There was a significant main effect of shock training (F(1, 30) = 57.08; p < 0.001) and a significant interaction between shock training and GRA treatment (F(1, 30) = 5.55; p = 0.025) on dark chamber-induced cFos in the vlBNST (Fig. 5a). Specifically, more vlBNST cFos activation was observed in shock retrained rats that were pretreated with GRA compared to those pretreated with saline (p = 0.031), with no effect of GRA treatment on vlBNST cFos in nonshocked rats. Approximately 12.9 more cFos+ nuclei per vlBNST ROI were present in rats pretreated with GRA compared to saline before reexposure to the shock-paired dark chamber (95% CI: 3.4, 25.3). A significant main effect of shock training on cFos activation within the PVN was also observed (F(1, 32) = 19.54; p < 0.001), with a marginally trending interaction between shock training and GRA treatment (F(1, 32) = 2.296; p = 0.14; Fig. 5d). Specifically, reexposure to the dark chamber in shock retrained rats strongly trended toward inducing more PVN cFos following GRA pretreatment compared to saline (p = 0.059), with no effect of GRA treatment in nonshocked rats. Approximately 74.6 more cFos+ nuclei/mm2 were counted within the PVN in shock-retrained rats pretreated with GRA versus saline (95% CI: 8.64, 137).

Fig. 5.

In food-deprived male rats that were previously retrained with footshock exposure (Shock +), systemic GRA administration increased the ability of dark chamber reexposure to activate cFos expression in DbH+ terminal-rich regions of the vlBNST and PVN. GRA did not alter cFos activation in nonshocked (Shock −) rats. a GRA pretreatment increased shock-paired dark chamber-induced cFos activation in the DbH+ terminal-rich region of vlBNST. b, c Representative images of nuclear cFos (red) and DbH+ terminal labeling (green) in fasted saline vehicle- (b) and GRA-pretreated (c) rats that were reexposed to the shock-paired dark chamber. ac, anterior commissure. d GRA pretreatment tended to increase shock-paired dark chamber-induced cFos activation in the DbH+ terminal-rich region of PVN. e, f Representative images of nuclear cFos (red) and DbH+ terminal labeling (green) in vehicle- (e) and GRA-pretreated (f) rats that were reexposed to the shock-paired dark chamber. 3rd V., third ventricle. Graphs display group mean ± SEM, with individual data points plotted. *p< 0.05. Scale bar in b = 100 µm, applies also to c, e, and f.

Fig. 5.

In food-deprived male rats that were previously retrained with footshock exposure (Shock +), systemic GRA administration increased the ability of dark chamber reexposure to activate cFos expression in DbH+ terminal-rich regions of the vlBNST and PVN. GRA did not alter cFos activation in nonshocked (Shock −) rats. a GRA pretreatment increased shock-paired dark chamber-induced cFos activation in the DbH+ terminal-rich region of vlBNST. b, c Representative images of nuclear cFos (red) and DbH+ terminal labeling (green) in fasted saline vehicle- (b) and GRA-pretreated (c) rats that were reexposed to the shock-paired dark chamber. ac, anterior commissure. d GRA pretreatment tended to increase shock-paired dark chamber-induced cFos activation in the DbH+ terminal-rich region of PVN. e, f Representative images of nuclear cFos (red) and DbH+ terminal labeling (green) in vehicle- (e) and GRA-pretreated (f) rats that were reexposed to the shock-paired dark chamber. 3rd V., third ventricle. Graphs display group mean ± SEM, with individual data points plotted. *p< 0.05. Scale bar in b = 100 µm, applies also to c, e, and f.

Close modal

We next examined potential relationships between cFos activation of A2 neurons and cFos activation in forebrain regions receiving input from A2 neurons (i.e., vlBNST and PVN). Across all shock retrained rats, there were strong positive within-subjects relationships between cFos activation of DbH+ cNTS neurons and cFos activation in the vlBNST (r(20) = 0.5093; p = 0.0155; Fig. 6a) and in the PVN (r(22) = 0.6494; p = 0.0006; Fig. 6b). Similar positive relationships occurred between cFos activation of PrRP+ cNTS neurons and cFos activation in the vlBNST (r(20) = 0.5497; p = 0.0080; Fig. 6c) and PVN (r(22) = 0.5488; p = 0.0055; Fig. 6d). No significant parallel relationships were observed in nonshocked rats. While such correlations do not prove causal relationships, they are consistent with the hypothesis that A2 neurons contribute to recruitment of neurons in downstream limbic and hypothalamic target regions.

Fig. 6.

Scatterplots depicting significant positive relationships between cFos activation of (a) DbH+ neurons in the cNTS and neurons in the vlBNST, (b) DbH+ neurons and neurons in the PVN, (c) PrRP+ neurons in the cNTS and neurons in the vlBNST, and (d) PrRP+ neurons in the cNTS and neurons in the PVN. Significant positive relationships were evident in rats that were retrained with footshock prior to dark chamber reexposure (shocked), but not in rats that were not retrained before dark chamber reexposure (nonshocked).

Fig. 6.

Scatterplots depicting significant positive relationships between cFos activation of (a) DbH+ neurons in the cNTS and neurons in the vlBNST, (b) DbH+ neurons and neurons in the PVN, (c) PrRP+ neurons in the cNTS and neurons in the vlBNST, and (d) PrRP+ neurons in the cNTS and neurons in the PVN. Significant positive relationships were evident in rats that were retrained with footshock prior to dark chamber reexposure (shocked), but not in rats that were not retrained before dark chamber reexposure (nonshocked).

Close modal

Acyl-Ghrelin Levels

To confirm that one or more rounds of overnight food deprivation elevates circulating ghrelin, we measured plasma levels of acyl-ghrelin in adult male rats exposed to a single overnight fast, and in rats exposed to a third round of overnight fasting. Acyl-ghrelin level in ad libitum-fed rats was measured to be 120.1 ± 8.0 pg/mL. Acyl-ghrelin levels rose to 192.3 ± 24.5 pg/mL following a single overnight fast, and to 399.9 ± 105.2 pg/mL following a third overnight fast. These data revealed a trending effect of food deprivation to increase plasma acyl-ghrelin (F(2, 7) = 3.851; p = 0.0745) and confirmed no decrement in the ability of overnight fasting to increase plasma ghrelin in rats exposed to three episodes of overnight fasting.

Results from the present study build on our previous findings that overnight food deprivation reduces conditioned passive avoidance behavior in adult male rats, with concurrent reduction of conditioned context-induced activation of cFos in PrRP+ NA neurons in the NTS and downstream target neurons in the vlBNST [7]. Here we demonstrate a role for ghrelin signaling in these fasting-induced behavioral and neural effects. Specifically, we show that systemic administration of GRA (presumed to counteract fasting-induced increases in ghrelin signaling) prior to the retention test enhances conditioned passive avoidance behavior (shown in Fig. 1) and neuronal cFos activation (Fig. 4, 5) in fasted rats. These novel findings support the view that reduced avoidance behavior and cFos activation in food-deprived rats is at least partly due to elevated ghrelin signaling.

We considered the possibility that reduced passive avoidance behavior in fasted rats with elevated ghrelin is due to a general reduction in memory retrieval, such that GRA may increase passive avoidance by improving memory of the shock-associated context. However, GRA treatment did not improve novel object recognition memory in food-deprived rats (shown in Fig. 2). A key distinction between mnemonic processes underlying passive avoidance versus novel object recognition is that the former but not the latter involves contextual memory [40, 41]. Previous research has shown that mice with a global ghrelin receptor knockout and rats with a vagal afferent-specific ghrelin receptor knockdown display impairment in hippocampal-dependent spatial and contextual novel object tasks [42, 43]. However, GRA effects on passive avoidance memory in the present study were in the opposite direction, such that GRA treatment improved avoidance memory in fasted rats. This discrepancy may be related to chronic rather than acute disruption of ghrelin signaling in the knockout/knockdown studies, which could interfere with other stages of memory formation. Alternatively, reduced performance in the “novel object in context” task by rodents with ghrelin receptor knockout/knockdown could reflect avoidance of the novel object. For example, Davis and colleagues [43] reported a negative shift in discrimination index in their vagal afferent ghrelin receptor knockdown model, such that knockdown rats spent less time exploring the novel object than would be expected if their behavior was due only to impaired memory of the familiar object.

If a fasting-induced elevation in ghrelin signaling is normally anxiolytic, then GRA treatment may reverse this effect to enhance general/innate anxiety-like behavior and avoidance displayed by nonfasted rats. Supporting this idea, previous work demonstrated that overnight food deprivation suppresses innate anxiety-like behavior in the elevated plus maze and light-enhanced acoustic startle tests [6], and in the open field test [44]. In the present study, GRA treatment did not alter innate anxiety-like behavior displayed by food-deprived rats in the open field test (shown in Fig. 3b, c), evidence that ghrelin signaling alone cannot fully explain the anxiolytic effect of food deprivation. A previous study reported that vagal afferent-specific ghrelin receptor knockdown does not alter anxiety-like behavior in the elevated zero maze [43], although rats in that experiment were not food deprived, so endogenous ghrelin presumably would have been relatively low in both knockdown and control rats.

Our findings demonstrate that GRA treatment enhanced the ability of reexposure to the shock-associated context to activate cFos expression in PrRP+ NA neurons in shock-retrained, fasted rats (shown in Fig. 4). These results are particularly interesting due to the suggested role of central PrRP signaling in stress responses and avoidance [45]. In nonfasted rodents, PrRP+ neurons in the cNTS are recruited by a variety of homeostatic and psychogenic stressors [6, 7, 10, 24, 25, 46], and stress-related neuroendocrine responses are modulated by PrRP signaling [24, 46‒49]. Further, administration of a PrRP analog has been reported to improve memory in a mouse model of Alzheimer’s disease [50]. These data and our current findings suggest a potential role for PrRP signaling in fear and memory and suggest a unique mechanism through which fasting-induced increases in ghrelin signaling may modulate the expression of conditioned avoidance behavior.

The ability of GRA treatment to enhance shock-paired context-induced cFos expression in PrRP+ A2 neurons is consistent with evidence that ghrelin suppresses the activity of vagal sensory afferents [29, 30] and suppresses activation of postsynaptic A2 neurons in the cNTS [31]. Our current results also are in line with our previous report that GRA enhances the ability of pharmacological vagal afferent stimulation to activate PrRP+ A2 neurons [20]. In that study [20] and in the current study, GRA treatment did not completely restore A2 neural cFos activation to levels observed in ad libitum-fed rats (i.e., see [7]). Thus, elevated ghrelin signaling during food deprivation contributes to but does not fully explain the A2 neural “silencing” effect of negative energy balance. Other contributing factors may include altered mechanosensory signals and/or hormonal signals [6, 51, 52].

Given the partial restoration of A2 neuronal cFos activation in shock-retrained, GRA-treated rats after reexposure to the shock-paired context, we examined concurrent cFos activation in DbH terminal-rich regions of the vlBNST and PVN; in rats, these DbH+ inputs arise primarily from caudal medullary A2 (and A1) NA neurons [53, 54]. Indeed, GRA increased activation of cFos within both regions in fasted rats that were reexposed to the shock-paired context (shown in Fig. 5). Importantly, GRA treatment prior to dark chamber reexposure did not influence cFos activation in PrRP+ NA neurons or within the vlBNST and PVN in rats that were not shocked during training (Fig. 4, 5). These data support the view that ghrelin signaling in fasted rats acts to limit aversive context-induced neural activation, without suppressing neural activation in response to a nonaversive context.

Based on significant positive relationships between cFos activation of PrRP+ and DbH+ cNTS neurons and activation of neurons within the vlBNST and PVN (shown in Fig. 6), we hypothesize that recruitment of A2 cNTS neurons in response to the shock-paired context promotes activation of downstream neurons within the vlBNST and PVN. To demonstrate a causal link between neural activation in these brain regions and their involvement in passive avoidance behavior, future research should specifically manipulate neural activity in these brain regions and circuits using pharmacological, optogenetic, chemogenetic, and/or lesioning strategies. For example, we previously used an NA-specific lesioning strategy to demonstrate that A2 NA inputs to the vlBNST and PVN are necessary for stress-induced innate avoidance and behavioral suppression [55‒57]. Interestingly, A2-derived NA signaling in the BNST has also been implicated in avoidance behavior conditioned by aversive opiate withdrawal [54, 58]. The current results provide new evidence, suggesting that A2 NA inputs to the vlBNST and/or PVN also participate in conditioned passive avoidance behavior.

The effect of GRA treatment on behavior and central cFos activation in the present study could reflect interference with either central or peripheral ghrelin signaling mechanisms. Ghrelin receptor mRNA is expressed by vagal sensory neurons in the nodose ganglia [29, 59] and by neurons within a variety of central brain regions [60‒64]. These central regions include the cNTS [60, 61] and the PVN [61], and regions considered to play a role in passive avoidance and fear memory [65], including the hippocampus [61, 62] and amygdala [63, 64]. Since systemic administration of the same GRA used in the present study was shown to block the effects of centrally administered ghrelin [66], central blockade of ghrelin receptors within these brain regions may have contributed to the behavioral and neural effects of GRA in our experiments. Additional work will be needed to differentiate between peripheral/vagally mediated versus centrally mediated ghrelin signaling in conditioned avoidance behavior. Future research also should explore sex differences in passive avoidance behavior and the role of ghrelin signaling (and other interoceptive feedback signals) in that behavior, given our previous report that food deprivation suppresses conditioned passive avoidance in male, but not female, rats [7]. In this regard, recent evidence indicates that female rats have significantly higher plasma levels of acyl-ghrelin compared to male rats under both fed and fasted conditions, and that females may be more sensitive to the anxiolytic effects of fasting-induced ghrelin signaling [28]. We reported that compared to male rats, female rats display markedly less conditioned passive avoidance behavior regardless of metabolic state at testing, consistent with other reports that female rodents show less passive and more active responses to threatening stimuli [7]. Thus, an active avoidance learning and testing approach is likely more suitable to explore potential effects of ghrelin signaling on behavioral (and neural) responses to conditioned aversive stimuli in females.

In summary, our results demonstrate a role for endogenous ghrelin signaling in the ability of negative energy balance to reduce conditioned avoidance behavior in male rats. We further demonstrate that GRA treatment enhances the ability of a footshock-conditioned context to activate PrRP+ A2 NA neurons, and to activate neurons in the downstream targets of these cNTS neurons (i.e., vlBNST and PVN) in fasted male rats. These findings support the view that interoceptive feedback from body to brain modulates learned avoidance behavior, and that a ghrelin-sensitive circuit contributes to this modulatory effect.

This study protocol was reviewed and approved by Florida State University Animal Care and Use Committee (#202000001) and was conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

The authors have no conflicts of interest to declare.

Research reported in this paper was funded by the National Institutes of Health grants F31MH119784 (C.M.E.) and R01MH59911 (L.R.).

Caitlyn M. Edwards and Linda Rinaman designed the experiments. Caitlyn M. Edwards, Inge Estefania Guerrero, Huiyuan Zheng, and Tyla Dolezel performed the experiments and analyzed the resulting data. Caitlyn M. Edwards, Inge Estefania Guerrero, and Linda Rinaman wrote the manuscript.

All data generated during this study are included in this article. Further enquiries can be directed to the corresponding author. A preprint version of this article is available on bioRxiv [67].

1.
American Psychiatric Association
.
Diagnostic and statistical manual of mental disorders: DSM 5
.
Arlington (VA)
:
American Psychiatric Publishing
;
2013
.
2.
Pittig
A
,
Treanor
M
,
LeBeau
RT
,
Craske
MG
.
The role of associative fear and avoidance learning in anxiety disorders: gaps and directions for future research
.
Neurosci Biobehav Rev
.
2018
;
88
:
117
40
. (March) https://doi.org/10.1016/j.neubiorev.2018.03.015.
3.
Dymond
S
.
Overcoming avoidance in anxiety disorders: the contributions of Pavlovian and operant avoidance extinction methods
.
Neurosci Biobehav Rev
.
2019
;
98
:
61
70
. (October 2018) https://doi.org/10.1016/j.neubiorev.2019.01.007.
4.
Maniscalco
JW
,
Rinaman
L
.
Vagal interoceptive modulation of motivated behavior
.
Physiology
.
2018
;
33
(
2
):
151
67
.
5.
Lutter
M
,
Sakata
I
,
Osborne-Lawrence
S
,
Rovinsky
SA
,
Anderson
JG
,
Jung
S
,
.
The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress
.
Nat Neurosci
.
2008 Jul 15
;
11
(
7
):
752
3
.
6.
Maniscalco
JW
,
Zheng
H
,
Gordon
PJ
,
Rinaman
L
.
Negative energy balance blocks neural and behavioral responses to acute stress by “silencing” central glucagon-like peptide 1 signaling in rats
.
J Neurosci
.
2015 Jul 29
;
35
(
30
):
10701
14
.
7.
Edwards
CM
,
Dolezel
T
,
Rinaman
L
.
Sex and metabolic state interact to influence expression of passive avoidance memory in rats: potential contribution of A2 noradrenergic neurons
.
Physiol Behav
.
2021
;
239
:
113511
.
8.
Klarer
M
,
Arnold
M
,
Gunther
L
,
Winter
C
,
Langhans
W
,
Meyer
U
.
Gut vagal afferents differentially modulate innate anxiety and learned fear
.
J Neurosci
.
2014
;
34
(
21
):
7067
76
.
9.
Foster
JA
,
Rinaman
L
,
Cryan
JF
.
Stress & the gut-brain axis: regulation by the microbiome
.
Neurobiol Stress
.
2017
;
7
:
124
36
.
10.
Holt
MK
,
Rinaman
L
.
The role of nucleus of the solitary tract glucagon-like peptide-1 and prolactin-releasing peptide neurons in stress: anatomy, physiology and cellular interactions
.
Br J Pharmacol
.
2021
:
1
17
. (January).
11.
Shapiro
RE
,
Miselis
RR
.
The central organization of the vagus nerve innervating the stomach of the rat
.
J Comp Neurol
.
1985
;
238
(
4
):
473
88
.
12.
Altschuler
SM
,
Bao
XM
,
Bieger
D
,
Hopkins
DA
,
Miselis
RR
.
Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary and spinal trigeminal tracts
.
J Comp Neurol
.
1989
;
283
(
2
):
248
68
.
13.
Raybould
HE
.
Gut chemosensing: interactions between gut endocrine cells and visceral afferents
.
Auton Neurosci
.
2010 Feb
;
153
(
1–2
):
41
6
.
14.
Mayer
EA
.
Gut feelings: the emerging biology of gut-brain communication
.
Nat Rev Neurosci
.
2011
;
12
(
8
):
453
66
.
15.
Dockray
GJ
.
Gastrointestinal hormones and the dialogue between gut and brain
.
J Physiol
.
2014
;
592
(
14
):
2927
41
.
16.
Appleyard
SM
,
Marks
D
,
Kobayashi
K
,
Okano
H
,
Low
MJ
,
Andresen
MC
.
Visceral afferents directly activate catecholamine neurons in the solitary tract nucleus
.
J Neurosci
.
2007
;
27
(
48
):
13292
302
.
17.
Rinaman
L
.
Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions
.
Am J Physiol Regul Integr Comp Physiol
.
2011
;
300
(
2
):
222
35
.
18.
Mönnikes
H
,
Lauer
G
,
Arnold
R
.
Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat
.
Brain Res
.
1997
;
770
(
1–2
):
277
88
.
19.
Maniscalco
JW
,
Rinaman
L
.
Overnight food deprivation markedly attenuates hindbrain noradrenergic, glucagon-like peptide-1, and hypothalamic neural responses to exogenous cholecystokinin in male rats
.
Physiol Behav
.
2013 Sep
;
121
:
35
42
.
20.
Maniscalco
JW
,
Edwards
CM
,
Rinaman
L
.
Ghrelin signaling contributes to fasting-induced attenuation of hindbrain neural activation and hypophagic responses to systemic cholecystokinin in rats
.
Am J Physiol Regul Integr Comp Physiol
.
2020
;
318
(
5
):
R1014
23
.
21.
Chen
YW
,
Das
M
,
Oyarzabal
EA
,
Cheng
Q
,
Plummer
NW
,
Smith
KG
,
.
Genetic identification of a population of noradrenergic neurons implicated in attenuation of stress-related responses
.
Mol Psychiatry
.
2019
;
24
(
5
):
710
25
.
22.
Aklan
I
,
Sayar Atasoy
N
,
Yavuz
Y
,
Ates
T
,
Coban
I
,
Koksalar
F
,
.
NTS catecholamine neurons mediate hypoglycemic hunger via medial hypothalamic feeding pathways
.
Cell Metab
.
2020
;
31
(
2
):
313
26.e5
.
23.
Roman
CW
,
Derkach
VA
,
Palmiter
RD
.
Genetically and functionally defined NTS to PBN brain circuits mediating anorexia
.
Nat Commun
.
2016
;
7
:
11905
. (May) https://doi.org/10.1038/ncomms11905.
24.
Zhu
LL
,
Onaka
T
.
Facilitative role of prolactin-releasing peptide neurons in oxytocin cell activation after conditioned-fear stimuli
.
Neuroscience
.
2003
;
118
(
4
):
1045
53
.
25.
Morales
T
,
Sawchenko
PE
.
Brainstem prolactin-releasing peptide neurons are sensitive to stress and lactation
.
Neuroscience
.
2003
;
121
(
3
):
771
8
.
26.
Tschop
M
,
Smiley
DL
,
Heiman
ML
.
Ghrelin induces adiposity in rodents
.
Nature
.
2000
;
407
(
6806
):
908
13
.
27.
Cummings
DE
,
Purnell
JQ
,
Frayo
RS
,
Schmidova
K
,
Wisse
BE
,
Weigle
DS
.
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
.
Diabetes
.
2001
;
50
(
8
):
1714
9
.
28.
Börchers
S
,
Krieger
JP
,
Maric
I
,
Carl
J
,
Abraham
M
,
Longo
F
,
.
From an empty stomach to anxiolysis: molecular and behavioral assessment of sex differences in the ghrelin Axis of rats
.
Front Endocrinol
.
2022 Jun
;
13
:
901669
16
.
29.
Date
Y
,
Murakami
N
,
Toshinai
K
,
Matsukura
S
,
Niijima
A
,
Matsuo
H
,
.
The role of the gastric afferent vagal nerve in Ghrelin-induced feeding and growth hormone secretion in rats
.
Gastroenterology
.
2002
;
123
(
4
):
1120
8
.
30.
Date
Y
,
Toshinai
K
,
Koda
S
,
Miyazato
M
,
Shimbara
T
,
Tsuruta
T
,
.
Peripheral interaction of ghrelin with cholecystokinin on feeding regulation
.
Endocrinology
.
2005
;
146
(
8
):
3518
25
.
31.
Cui
RJ
,
Li
X
,
Appleyard
SM
.
Ghrelin inhibits visceral afferent activation of catecholamine neurons in the solitary tract nucleus
.
J Neurosci
.
2011
;
31
(
9
):
3484
92
. (October 2009) https://doi.org/10.1523/JNEUROSCI.3187-10.2011.
32.
Spencer
SJ
,
Xu
L
,
Clarke
MA
,
Lemus
M
,
Reichenbach
A
,
Geenen
B
,
.
Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress
.
Biol Psychiatry
.
2012
;
72
(
6
):
457
65
.
33.
Harmatz
ES
,
Stone
L
,
Lim
SH
,
Lee
G
,
Mcgrath
A
,
Gisabella
B
,
.
Central ghrelin resistance permits the overconsolidation of fear memory
.
Biol Psychiatry
.
2017
;
81
(
12
):
1003
13
.
34.
Watson
RE
,
Wiegand
SJ
,
Clough
RW
,
Hoffman
GE
.
Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology
.
Peptides
.
1986
;
7
(
1
):
155
9
.
35.
Maruyama
M
,
Matsumoto
H
,
Fujiwara
K
,
Kitada
C
,
Hinuma
S
,
Onda
H
,
.
Immunocytochemical localization of prolactin-releasing peptide in the rat brain
.
Endocrinology
.
1999
;
140
(
5
):
2326
33
.
36.
Lin
SHS
,
Leslie
FM
,
Civelli
O
.
Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception
.
Brain Res
.
2002
;
952
(
1
):
15
30
.
37.
Ruxton
GD
.
The unequal variance t test is an underused alternative to Student’s t test and the Mann-Whitney U test
.
Behav Ecol
.
2006
;
17
(
4
):
688
90
.
38.
Calin-Jageman
RJ
,
Cumming
G
.
Estimation for better inference in neuroscience
.
eNeuro
.
2019 Aug
;
6
(
4
):
1
11
.
39.
Ho
J
,
Tumkaya
T
,
Aryal
S
,
Choi
H
,
Claridge-Chang
A
.
Moving beyond P values: data analysis with estimation graphics
.
Nat Methods
.
2019
;
16
(
7
):
565
6
.
40.
Atucha
E
,
Roozendaal
B
.
The inhibitory avoidance discrimination task to investigate accuracy of memory
.
Front Behav Neurosci
.
2015 Mar
;
9
:
60
.
41.
Lueptow
LM
.
Novel object recognition test for the investigation of learning and memory in mice
.
J Vis Exp
.
2017
;
2017
(
126
):
1
9
.
42.
Diano
S
,
Farr
SA
,
Benoit
SC
,
McNay
EC
,
Da Silva
I
,
Horvath
B
,
.
Ghrelin controls hippocampal spine synapse density and memory performance
.
Nat Neurosci
.
2006
;
9
(
3
):
381
8
.
43.
Davis
EA
,
Wald
HS
,
Suarez
AN
,
Zubcevic
J
,
Liu
CM
,
Cortella
AM
,
.
Ghrelin signaling affects feeding behavior, metabolism, and memory through the vagus nerve
.
Curr Biol
.
2020
;
30
(
22
):
4510
8.e6
.
44.
Heiderstadt
KM
,
McLaughlin
RM
,
Wright
DC
,
Walker
SE
,
Gomez-Sanchez
CE
.
The effect of chronic food and water restriction on open-field behaviour and serum corticosterone levels in rats
.
Lab Anim
.
2000
;
34
(
1
):
20
8
.
45.
Holt
MK
,
Rinaman
L
.
The role of nucleus of the solitary tract glucagon-like peptide-1 and prolactin-releasing peptide neurons in stress: anatomy, physiology and cellular interactions
.
Br J Pharmacol
.
2022
;
179
(
4
):
642
58
.
46.
Uchida
K
,
Kobayashi
D
,
Das
G
,
Onaka
T
,
Inoue
K
,
Itoi
K
.
Participation of the prolactin-releasing peptide-containing neurones in caudal medulla in conveying haemorrhagic stress-induced signals to the paraventricular nucleus of the hypothalamus
.
J Neuroendocrinol
.
2010
;
22
(
1
):
33
42
. https://doi.org/10.1111/j.1365-2826.2009.01935.x.
47.
Yoshida
M
,
Takayanagi
Y
,
Onaka
T
.
The medial amygdala-medullary PrRP-synthesizing neuron pathway mediates neuroendocrine responses to contextual conditioned fear in male rodents
.
Endocrinology
.
2014
;
155
(
8
):
2996
3004
.
48.
Ohiwa
N
,
Chang
H
,
Saito
T
,
Onaka
T
,
Fujikawa
T
,
Soya
H
.
Possible inhibitory role of prolactin-releasing peptide for ACTH release associated with running stress
.
Am J Physiol Regul Integr Comp Physiol
.
2007
;
292
(
1
):
497
504
.
49.
Mochiduki
A
,
Takeda
T
,
Kaga
S
,
Inoue
K
.
Stress response of prolactin-releasing peptide knockout mice as to glucocorticoid secretion
.
J Neuroendocrinol
.
2010
;
22
(
6
):
576
84
.
50.
Popelová
A
,
Pražienková
V
,
Neprašová
B
,
Kasperová
BJ
,
Hrubá
L
,
Holubová
M
,
.
Novel lipidized analog of prolactin-releasing peptide improves memory impairment and attenuates hyperphosphorylation of tau protein in a mouse model of tauopathy
.
J Alzheimers Dis
.
2018
;
62
(
4
):
1725
36
.
51.
Dallman
MF
,
Akana
SF
,
Bhatnagar
S
,
Bell
ME
,
Choi
SJ
,
Chu
A
,
.
Starvation: early signals, sensors, and sequelae
.
Endocrinology
.
1999
;
140
(
9
):
4015
23
.
52.
Maniscalco
JW
,
Rinaman
L
.
Interoceptive modulation of neuroendocrine, emotional, and hypophagic responses to stress
.
Physiol Behav
.
2017 Jul
;
176
:
195
206
.
53.
Sawchenko
PE
,
Swanson
LW
.
The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat
.
Brain Res
.
1982
;
257
(
3
):
275
325
.
54.
Delfs
JM
,
Zhu
Y
,
Druhan
JP
,
Aston-Jones
G
.
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
.
Nature
.
2000
;
403
(
6768
):
430
4
. (January) https://doi.org/10.1038/35000212.
55.
Banihashemi
L
,
Rinaman
L
.
Noradrenergic inputs to the bed nucleus of the stria terminalis and paraventricular nucleus of the hypothalamus underlie hypothalamic-pituitary- adrenal axis but not hypophagic or conditioned avoidance responses to systemic yohimbine
.
J Neurosci
.
2006
;
26
(
44
):
11442
53
.
56.
Zheng
H
,
Rinaman
L
.
Yohimbine anxiogenesis in the elevated plus maze requires hindbrain noradrenergic neurons that target the anterior ventrolateral bed nucleus of the stria terminalis
.
Eur J Neurosci
.
2013 Apr
;
37
(
8
):
1340
9
.
57.
Rinaman
L
,
Dzmura
V
.
Experimental dissociation of neural circuits underlying conditioned avoidance and hypophagic responses to lithium chloride
.
Am J Physiol Regul Integr Comp Physiol
.
2007
;
293
(
4
):
1495
503
.
58.
Aston-Jones
G
,
Delfs
JM
,
Druhan
J
,
Zhu
Y
.
The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal
.
Ann N Y Acad Sci
.
1999
;
877
(
151
):
486
98
.
59.
Burdyga
G
,
Varro
A
,
Dimaline
R
,
Thompson
DG
,
Dockray
GJ
.
Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance
.
Am J Physiol Gastrointest Liver Physiol
.
2006
;
290
(
6
):
1289
97
.
60.
Lin
Y
,
Matsumura
K
,
Fukuhara
M
,
Kagiyama
S
,
Fujii
K
,
Iida
M
.
Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats
.
Hypertension
.
2004
;
43
(
5
):
977
82
.
61.
Zigman
JM
,
Jones
JE
,
Lee
CE
,
Saper
CB
,
Elmquist
JK
.
Expression of ghrelin receptor mRNA in the rat and the mouse brain
.
J Comp Neurol
.
2006
;
494
(
3
):
528
48
.
62.
Guan
XM
,
Yu
H
,
Palyha
OC
,
McKee
KK
,
Feighner
SD
,
Sirinathsinghji
DJS
,
.
Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues
.
Brain Res Mol Brain Res
.
1997
;
48
(
1
):
23
9
.
63.
Alvarez-Crespo
M
,
Skibicka
KP
,
Farkas
I
,
Molnár
CS
,
Egecioglu
E
,
Hrabovszky
E
,
.
The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence
.
PLoS One
.
2012
;
7
(
10
):
e46321
10
.
64.
Mani
BK
,
Walker
AK
,
Lopez Soto
EJ
,
Raingo
J
,
Lee
CE
,
Perelló
M
,
.
Neuroanatomical characterization of a growth hormone secretagogue receptor-green fluorescent protein reporter mouse
.
J Comp Neurol
.
2014 Nov 1
;
522
(
16
):
3644
66
.
65.
Izquierdo
I
,
Furini
CRG
,
Myskiw
JC
.
Fear memory
.
Physiol Rev
.
2016
;
96
(
2
):
695
750
.
66.
Brockway
ET
,
Krater
KR
,
Selva
JA
,
Wauson
SER
,
Currie
PJ
.
Impact of [d-Lys3]-GHRP-6 and feeding status on hypothalamic ghrelin-induced stress activation
.
Peptides
.
2016
;
79
:
95
102
.
67.
Edwards
CM
,
Guerrero
IE
,
Dolezel
T
,
Zheng
H
,
Rinaman
L
.
Blockade of ghrelin receptor signaling enhances conditioned passive avoidance and context-associated neural circuit activation in fasted male rats
.
bioRxiv
.
2022
. September 13, 2022, https://doi.org/10.1101/2022.02.11.480168.